FDA Adverse Event Malfunction Summary report: N

INDIGO SYSTEM CATD ASPIRATION CATHETER

MDR report key: 10462555 · Received August 27, 2020

Report

Report Number
3005168196-2020-01296
Event Type
Malfunction
Date Received
August 27, 2020
Date of Event
August 4, 2020
Report Date
August 4, 2020
Manufacturer
PENUMBRA, INC.
Product Code
DXE
PMA / PMN Number
K142870
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

RESULTS: THE CATD WAS KINKED APPROXIMATELY 39.5 CM FROM THE HUB. CONCLUSIONS: EVALUATION OF THE RETURNED CATD CONFIRMED THAT THE CATHETER WAS KINKED. IF THE CATD IS FORCEFULLY MISHANDLED DURING USE, DAMAGE SUCH AS A KINK MAY OCCUR. DURING THE FUNCTIONAL TEST, THE CATD WAS CONNECTED TO A DEMONSTRATION ASPIRATION TUBING, CANISTER, AND PUMP. THE PUMP WAS POWERED ON AND FLUID WAS ASPIRATED INTO THE CANISTER. PENUMBRA CATHETERS ARE VISUALLY INSPECTED DURING IN-PROCESS INSPECTION AND DURING QUALITY AFTER MANUFACTURING. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Additional Manufacturer Narrative · 1

THE DEVICE HAS BEEN RETURNED AND THE INVESTIGATION RESULTS ARE PENDING. A FOLLOW UP MDR WILL BE SUBMITTED UPON COMPLETION OF THE DEVICE INVESTIGATION. ADDITIONAL 510(K)#S THAT ALSO APPLY TO THIS COMPLAINT: K160533; K161523.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE USING AN INDIGO SYSTEM CATD ASPIRATION CATHETER (CATD). DURING THE PROCEDURE, WHILE PERFORMING ASPIRATION, THE PHYSICIAN NOTICED UNDER FLUOROSCOPY THAT THE DISTAL END OF THE CATD KINKED AND WAS NO LONGER ASPIRATING THE CLOT. THEREFORE, THE CATD WAS REMOVED. THE PROCEDURE WAS COMPLETED USING ANOTHER CATD. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
925648 INDIGO SYSTEM CATD ASPIRATION CATHETER DXE DXE PENUMBRA, INC. F89811

Patients

Seq Age Sex Outcome Treatment
1 73 YR